Study supports value of sigmoidoscopy, an alternative to colonoscopy

May 21, 2012 By Randy Dotinga, HealthDay Reporter
Study supports value of sigmoidoscopy, an alternative to colonoscopy
Research suggests the test can help prevent colon cancer incidence, deaths.

(HealthDay) -- New research confirms that sigmoidoscopies -- less-invasive alternatives to colonoscopies that don't require sedation -- are effective in lowering the risk of colon cancer.

Having the procedure lowered the risk of getting a colon by 21 percent and the chances of dying from the disease by 26 percent, the researchers reported.

Many doctors no longer offer sigmoidoscopies, but an editorial accompanying the study pointed out that sigmoidoscopies are still a good option for some patients.

"Physicians need to find out which colorectal cancer screening test the patient sitting in front of them will do, and recommend that test," said editorial author Dr. John Inadomi, a professor of medicine at the University of Washington School of Medicine in Seattle. "It's the test the patient wants to do -- not the test the doctor wants them to do -- that is important."

Colon and rectal cancers kill more than 51,000 people a year in the United States, according to the . Colonoscopies allow doctors to view the lining of the entire colon as they engage in search-and-destroy missions against polyps that could develop into cancer.

Sigmoidoscopies use a smaller scope that searches only the lower colon, potentially missing some . Patients can return to home or work right after the procedure because they are not sedated.

Both kinds of screening require a notoriously unpleasant cleansing of the colon via a liquid laxative. However, sigmoidoscopies require less laxative consumption than colonoscopies, Inadomi said.

But there is a hitch to sigmoidoscopies: If the procedure turns up potentially dangerous polyps, they need to be removed during a subsequent .

In the new study, researchers randomly assigned half of 154,900 people aged 55 to 74 to sigmoidoscopies -- 84 percent actually got them -- and tried to get those patients to return for a second three to five years later. The study lasted from 1993 to 2001.

The risk of deaths in the patients overall was small -- 593 occurred over an average of 12 years of follow-up. But the risk fell by 26 percent in those who had the procedures compared to people in the usual care group, who only got colonoscopies or sigmoidoscopies if they asked for one or their doctor recommended one. The researchers estimated that if they had used colonoscopies rather than sigmoidoscopies in their study, they would have spotted 16 percent more cancers.

However, the researchers discovered that even colonoscopies sometimes failed to find precancerous polyps.

When it comes to the ability of regular colonoscopies to detect polyps, "we may have to do better," said study author Dr. Robert Schoen, a professor of medicine and epidemiology at the University of Pittsburgh School of Medicine. "Or maybe we can't do better."

The study appears online May 21 in the New England Journal of Medicine, to coincide with a presentation at the annual Digestive Diseases Week meeting in Chicago.

Explore further: Study: Colonoscopy cuts colon cancer death risk

More information: For more about colon cancer, try the U.S. National Library of Medicine.

Related Stories

Study: Colonoscopy cuts colon cancer death risk

February 22, 2012
(AP) -- Millions of people have endured a colonoscopy, believing the dreaded exam may help keep them from dying of colon cancer. For the first time, a major study offers clear evidence that it does.

Study: Simple scope exam cuts colon cancer deaths

May 21, 2012
A simple, cheaper exam of just the lower part of the bowel can cut the risk of developing colon cancer or dying of the disease, a large federal study finds.

Poor colonoscopy prep hides pre-cancerous polyps

March 27, 2012
(Medical Xpress) -- What happens on the day before a colonoscopy may be just as important as the colon-screening test itself.

Recommended for you

Clinical trial suggests new cell therapy for relapsed leukemia patients

November 20, 2017
A significant proportion of children and young adults with treatment-resistant B-cell leukemia who participated in a small study achieved remission with the help of a new form of gene therapy, according to researchers at ...

Researchers discover a new target for 'triple-negative' breast cancer

November 20, 2017
So-called "triple-negative" breast cancer is a particularly aggressive and difficult-to-treat form. It accounts for only about 10 percent of breast cancer cases, but is responsible for about 25 percent of breast cancer fatalities.

Study reveals new mechanism used by cancer cells to disarm attacking immune cells

November 20, 2017
A new study by researchers at The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute (OSUCCC - James) identifies a substance released by pancreatic cancer cells that protects ...

Cell-weighing method could help doctors choose cancer drugs

November 20, 2017
Doctors have many drugs available to treat multiple myeloma, a type of blood cancer. However, there is no way to predict, by genetic markers or other means, how a patient will respond to a particular drug. This can lead to ...

Lung cancer triggers pulmonary hypertension

November 17, 2017
Shortness of breath and respiratory distress often increase the suffering of advanced-stage lung cancer patients. These symptoms can be triggered by pulmonary hypertension, as scientists at the Max Planck Institute for Heart ...

Researchers discover an Achilles heel in a lethal leukemia

November 16, 2017
Researchers have discovered how a linkage between two proteins in acute myeloid leukemia enables cancer cells to resist chemotherapy and showed that disrupting the linkage could render the cells vulnerable to treatment. St. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.